Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction ...

Biotechnology leader Regeneron Pharmaceuticals is acquiring genetic testing firm 23andMe for $256 million following its ...

The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK ...

North Carolinians have a limited time to file claims against genetic testing company 23andMe for the 2023 data breach.

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

The co-hosts of "The View" melted down over a new book out Tuesday on the cover-up of President Biden's decline in office, as ...

Regeneron acquires bankrupt 23andMe for $256M, taking over its DNA database and services while pledging to uphold privacy ...

Regeneron Pharmaceuticals has said it will preserve the privacy of 23andMe's genetic data after it acquires the DNA testing ...

Genetic testing company 23andMe is being acquired, shortly after it declared bankruptcy months ago.

North Carolinians have until July 14th, to file claims against DNA testing company 23andMe for any general claims against the ...

RALEIGH, N.C. (WITN) - The deadline to file claims against a DNA testing company has been announced. In October 2023, 23andMe ...

Attorney General Jeff Jackson announced that North Carolinians can file claims against a DNA testing company related to a ...